A Phase 1b, Pilot Trial Evaluating the Safety and Pharmacodynamic Effects of SRD-001 (AAV1-SERCA2a) in Subjects with Heart Failure with Preserved Ejection Fraction
Clinical Trial Grant
Awarded By
Sardocor Corp.
Start Date
July 27, 2023
End Date
July 1, 2028
Awarded By
Sardocor Corp.
Start Date
July 27, 2023
End Date
July 1, 2028